From January 1, 2023 to March 31, 2023, the company has repurchased 5,200,000 shares, representing 7.97% for $55.1 million. With this, the company has completed the repurchase of 17,939,115 shares, representing 25.19% for $183.26 million under the buyback announced on September 19, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.41 USD | +0.84% | -7.79% | -25.18% |
05-23 | Transcript : Theravance Biopharma, Inc. - Special Call | |
05-13 | Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.18% | 409M | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.21% | 238B | |
+7.06% | 204B | |
-6.18% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- TBPH Stock
- News Theravance Biopharma, Inc.
- Tranche Update on Theravance Biopharma, Inc.'s Equity Buyback Plan announced on September 19, 2022.